Loading stock…

Agilent Technologies, Inc. (A) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Agilent Technologies, Inc.

AMarket cap $48BPrice $169.3

Country🇺🇸United States

SectorHealthcare

IndustryLife Sciences

Makes the instruments and software labs use to analyze everything from blood samples to pesticides in food. Its equipment sits behind most drug approvals and quality tests you never see but constantly rely on.

In Bastion Portfolios?

52W Return+20%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+0%3

Revenue Forecast

Rev CAGR (1y)+8%5

Rev CAGR (3y)+7%5

Rev CAGR (5y)+7%6

Earnings Forecast

EPS Growth Y+1+36%9

EPS Growth Y+2+9%6

EPS Growth Y+3+10%6

Quality

Margins

EBIT Margin25%8

Net Income Margin20%8

Free Cash Flow Margin17%7

Debt

Net Debt/EBITDA1.16

Efficiency

ROE21%8

ROA11%9

Earnings Stability1010

GEAR+STRONG68

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)263

P/E Ratio (Forward 3y)232

P/BV6.53

EV Multiples

EV/EBITDA Fwd232

EV/EBIT Fwd253

Yield

Free Cash Flow Yield2.7%4

Dividend Yield0.6%2

Momentum

Short term

1 month return+12%10

3 month return+29%10

YTD return+25%8

Mid term

Price vs 52wHigh96%10

1 year return+23%7

Long term

3 year return+56%6

5 year return+13%4

Risk Shield

Price Risk

Beta1.04

Volatility32%6

Free Cash Flow

Free Cash Flow Margin17%7

Free Cash Flow Yield2.7%4

Quality

ROCE16%8

Earnings Stability1010

Net Debt/EBITDA1.16

02Growth

Is it actually growing, and how fast?

AAgilent Technologies

Revenue FY25$6.9B

GROWTH RATING↗

AVERAGE49 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+0%3

Revenue, next 1Y+8%5

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+36%9

EPS growth, FY27E+9%6

EPS growth, FY28E+10%6

GROWTH ASSESSMENT

STRENGTHS

Revenue held flat over the last 3 years and is set to grow 7%/yr from here.

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 7%/yr).

WATCH

A mid-pack grower, ahead of 49% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, in line with the market.5/10

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

WEAKNESSES

Revenue held flat over the last 3 years, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's speeding up. The one thing to watch: the 3-year revenue record is weak.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG88 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+12%10

3-month return+29%10

YTD return+25%8

MID & LONG-TERM▾SCORE

% of 52-week high96%10

1-year return+23%7

3-year return+56%6

5-year return+13%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 23% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+12%), over three months (+29%) and so far this year (+25%).

WATCH

Average long-term results. Multi-year returns are middling (+56% over three years and +13% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Agilent. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

AAgilent Technologies

Revenue FY25$6.9B

GROWTH RATING↗

AVERAGE49 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+0%3

Revenue, next 1Y+8%5

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+36%9

EPS growth, FY27E+9%6

EPS growth, FY28E+10%6

GROWTH ASSESSMENT

STRENGTHS

Revenue held flat over the last 3 years and is set to grow 7%/yr from here.

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 7%/yr).

WATCH

A mid-pack grower, ahead of 49% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, in line with the market.5/10

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

WEAKNESSES

Revenue held flat over the last 3 years, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's speeding up. The one thing to watch: the 3-year revenue record is weak.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG88 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+12%10

3-month return+29%10

YTD return+25%8

MID & LONG-TERM▾SCORE

% of 52-week high96%10

1-year return+23%7

3-year return+56%6

5-year return+13%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 23% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+12%), over three months (+29%) and so far this year (+25%).

WATCH

Average long-term results. Multi-year returns are middling (+56% over three years and +13% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Agilent. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community